Ultralife Corp
ULBINasdaqCIK 875657TechnologyFiscal year ends Dec 31
Reports and events: 285 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000933430-26-000005 |
| 2026-10-2812:13 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-033731 |
| 2026-08-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026573 |
| 2026-08-0707:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026432 |
| 2026-07-2316:27 ET | 8-K | 5.07 Shareholder vote results | 0001437749-26-024330 |
| 2026-06-0213:07 ET | DEF 14A | Proxy statementPeriod 2026-07-22 | 0001437749-26-019134 |
| 2026-05-0807:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-015750 |
| 2026-05-0807:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015749 |
| 2026-04-2908:29 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001437749-26-013737 |
| 2026-03-2316:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-009385 |
| 2026-03-1619:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000933430-26-000003 |
| 2026-03-1017:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-007567 |
| 2025-11-1807:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-035515 |
| 2025-11-1717:26 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-035475 |
| 2025-08-2714:06 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-25-027836 |
| 2025-08-0716:55 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-025484 |
| 2025-08-0716:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-025482 |
| 2025-07-1716:16 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-022930 |
| 2025-05-2713:03 ET | DEF 14A | Proxy statementPeriod 2025-07-16 | 0001437749-25-018420 |
| 2025-05-1216:38 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-016140 |
| 2025-05-0907:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015629 |
| 2025-04-2816:51 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001437749-25-013351 |
| 2025-04-0107:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-010360 |
| 2025-04-0107:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-010359 |
| 2025-01-1616:00 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001437749-25-001267 |
| 2024-11-1217:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034608 |
| 2024-11-0807:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034046 |
| 2024-11-0617:09 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-033673 |
| 2024-10-0317:23 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030645 |
| 2024-09-0316:15 ET | SC 13D/A | Ownership report, active investor, amended | 0000933430-24-000011 |
| 2024-07-2507:31 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-023416 |
| 2024-07-2507:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-023415 |
| 2024-07-1713:10 ET | 8-K | 5.07 Shareholder vote results | 0001437749-24-022896 |
| 2024-05-2913:01 ET | DEF 14A | Proxy statementPeriod 2024-07-16 | 0001437749-24-018566 |
| 2024-04-2615:29 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001437749-24-013405 |
| 2024-04-2507:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-013121 |
| 2024-04-2507:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-013119 |
| 2024-03-2116:47 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-008872 |
| 2024-02-1507:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-004266 |
| 2023-10-2607:32 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-029036 |
| 2023-10-2607:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-029034 |
| 2023-07-2707:31 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-020795 |
| 2023-07-2707:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-020793 |
| 2023-07-2115:51 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-020436 |
| 2023-05-3017:00 ET | DEF 14A | Proxy statementPeriod 2023-07-19 | 0001437749-23-016145 |
| 2023-05-0416:43 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-012590 |
| 2023-04-2814:28 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001437749-23-011580 |
| 2023-04-2707:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-011241 |
| 2023-03-3107:00 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-008694 |
| 2023-03-0209:30 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-005169 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.